These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123 [TBL] [Abstract][Full Text] [Related]
9. 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress. Luo T; Chen B; Wang X Chem Biol Interact; 2015 Dec; 242():99-106. PubMed ID: 26428355 [TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987 [TBL] [Abstract][Full Text] [Related]
11. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721 [TBL] [Abstract][Full Text] [Related]
12. The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure. Hirose M; Takano H; Hasegawa H; Tadokoro H; Hashimoto N; Takemura G; Kobayashi Y J Pharmacol Sci; 2017 Dec; 135(4):164-173. PubMed ID: 29249634 [TBL] [Abstract][Full Text] [Related]
13. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis. Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973 [TBL] [Abstract][Full Text] [Related]
14. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice. You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126 [TBL] [Abstract][Full Text] [Related]
15. Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF- Bai W; Ren M; Cheng W; Lu X; Liu D; Wang B Evid Based Complement Alternat Med; 2021; 2021():5577875. PubMed ID: 34007292 [TBL] [Abstract][Full Text] [Related]
16. Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects. Altieri P; Bertolotto M; Fabbi P; Sportelli E; Balbi M; Santini F; Brunelli C; Canepa M; Montecucco F; Ameri P Int J Cardiol; 2018 Nov; 271():219-227. PubMed ID: 29801760 [TBL] [Abstract][Full Text] [Related]
17. Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation. Kondo H; Abe I; Fukui A; Saito S; Miyoshi M; Aoki K; Shinohara T; Teshima Y; Yufu K; Takahashi N J Cardiol; 2018 Mar; 71(3):310-319. PubMed ID: 28993090 [TBL] [Abstract][Full Text] [Related]
18. TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice. Wang Z; Xu Y; Wang M; Ye J; Liu J; Jiang H; Ye D; Wan J EBioMedicine; 2018 Oct; 36():54-62. PubMed ID: 30297144 [TBL] [Abstract][Full Text] [Related]
19. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload. Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461 [TBL] [Abstract][Full Text] [Related]
20. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function. Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]